Study S001854

Effects of Single Doses of Liraglutide and Dapagliflozin on Hyperglycemia and Ketogenesis in Type 1 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02777073
Acronym: 1974
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: COMPLETED
Enrollment: 43
Start: 2016-03-01
Primary completion: 2016-12-01
Lead sponsor: University at Buffalo
Conditions: Type 1 Diabetes
Interventions: DRUG:Victoza; DRUG:Placebo; DRUG:Dapagliflozin 10mg Tab
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Difference in Ketone Bodies Formation After Single Dose of Liraglutide and Dapagliflozin [8 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.